OSTARA
0473.278.242 · rovalta.com · 24/09/2026
ACTIVE
OSTARA
Financial year 2025 · closed on 31/12/2025
Net result
-9,6 k €
-170.1% YoY
Gross margin
7,9 k €
-82.0% YoY
Equity
496,5 k €
-1.9% YoY
Overview
What does OSTARA do?
OSTARA is a Private limited company incorporated in 2000. Its registered office is in Heusden-Zolder.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0473.278.242
Incorporation
14/11/2000
Legal form
Private limited company
Registered office
De Lobbert 6
3550 Heusden-Zolder · FlandreSee on map
3550 Heusden-Zolder · FlandreSee on map
Contributed capital
5 260,82 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 7,9 k € | -82.0% | 43,9 k € | +48.1% | 29,6 k € | -82.3% | 167,4 k € | -11.5% | 189,2 k € | +9.7% | 172,4 k € | +7.2% | 160,9 k € | -6.9% | 172,8 k € | -1.3% | 175 k € | +62.3% | 107,9 k € | -26.9% | 147,5 k € | -24.4% | 195,1 k € | +38.9% | 140,5 k € | +4.6% | 134,3 k € | +19.6% | 112,3 k € | +7.6% | 104,4 k € | -2.3% | 106,8 k € | -13.5% | 123,5 k € | +16.9% | 105,7 k € | -8.5% | 115,5 k € |
| EBITDA | 3,2 k € | -92.3% | 41,5 k € | +51.2% | 27,4 k € | -73.0% | 101,5 k € | -6.4% | 108,5 k € | +27.2% | 85,2 k € | +35.1% | 63,1 k € | -18.8% | 77,7 k € | -4.5% | 81,3 k € | +32.0% | 61,6 k € | -52.0% | 128,3 k € | -33.3% | 192,3 k € | +39.1% | 138,3 k € | +4.9% | 131,8 k € | +19.9% | 109,9 k € | +5.9% | 103,8 k € | -1.4% | 105,3 k € | -14.0% | 122,3 k € | +18.1% | 103,6 k € | -8.8% | 113,6 k € |
| Operating result | -11,1 k € | -165% | 17,1 k € | +708% | 2,1 k € | -96.9% | 69,3 k € | +10.6% | 62,6 k € | +171% | 23,1 k € | +448% | -6,6 k € | -216% | 5,8 k € | -68.3% | 18,1 k € | +2148% | -885,6 € | -101% | 69,7 k € | -55.0% | 154,8 k € | +53.2% | 101,1 k € | +11.5% | 90,7 k € | +17.8% | 76,9 k € | -18.2% | 94 k € | -1.6% | 95,6 k € | -14.5% | 111,8 k € | +37.5% | 81,3 k € | -23.0% | 105,6 k € |
| Net result | -9,6 k € | -170% | 13,7 k € | +30093% | -45,7 € | -100% | 53 k € | +8.3% | 48,9 k € | +212% | 15,7 k € | +274% | -9 k € | -897% | 1,1 k € | -88.3% | 9,6 k € | +357% | -3,8 k € | -106% | 68 k € | -39.0% | 111,6 k € | +44.2% | 77,4 k € | +8.1% | 71,6 k € | +27.5% | 56,1 k € | -23.3% | 73,1 k € | -4.5% | 76,6 k € | -10.4% | 85,5 k € | +45.7% | 58,7 k € | -22.6% | 75,8 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 496,5 k € | -1.9% | 506,1 k € | +2.8% | 492,4 k € | -0.0% | 492,5 k € | -4.9% | 518 k € | +10.4% | 469,1 k € | +3.5% | 453,4 k € | -1.9% | 462,4 k € | -36.8% | 731,3 k € | +1.3% | 721,6 k € | -0.5% | 725,4 k € | -17.3% | 877,4 k € | +14.6% | 765,8 k € | +6.6% | 718,4 k € | +11.1% | 646,9 k € | +9.5% | 590,8 k € | +14.1% | 517,6 k € | +17.4% | 441 k € | +24.1% | 355,5 k € | +19.8% | 296,8 k € |
| Total assets | 501,3 k € | -3.9% | 521,6 k € | +4.2% | 500,4 k € | -11.1% | 562,9 k € | -20.7% | 710,2 k € | +35.1% | 525,7 k € | -9.4% | 580,1 k € | -4.6% | 608,1 k € | -26.1% | 822,7 k € | +0.8% | 816,5 k € | -2.7% | 838,8 k € | -13.5% | 969,3 k € | +12.5% | 862 k € | +4.0% | 829 k € | +1.9% | 813,5 k € | +30.5% | 623,5 k € | +12.3% | 555 k € | +15.3% | 481,4 k € | +21.0% | 397,8 k € | +16.6% | 341 k € |
| Cash | 12,2 k € | -68.4% | 38,5 k € | +125% | 17,2 k € | -89.0% | 156,4 k € | -38.1% | 252,8 k € | +142% | 104,3 k € | +95.2% | 53,4 k € | +38.9% | 38,5 k € | -46.5% | 72 k € | +78.6% | 40,3 k € | +148% | 16,2 k € | -79.1% | 77,5 k € | +55.3% | 49,9 k € | +49.7% | 33,3 k € | -63.9% | 92,3 k € | -54.9% | 204,6 k € | -38.2% | 331,2 k € | +615% | 46,3 k € | -75.3% | 187,4 k € | -17.8% | 228,1 k € |
| Debts | 4,8 k € | -68.9% | 15,4 k € | +93.1% | 8 k € | -70.6% | 27,2 k € | -76.6% | 116,4 k € | +106% | 56,4 k € | -55.4% | 126,4 k € | -12.7% | 144,9 k € | +59.5% | 90,8 k € | -3.9% | 94,5 k € | -16.6% | 113,4 k € | +23.5% | 91,8 k € | -3.4% | 95,1 k € | -12.7% | 108,9 k € | -34.0% | 164,9 k € | +405% | 32,6 k € | -12.4% | 37,3 k € | -7.4% | 40,3 k € | -4.5% | 42,2 k € | -4.3% | 44,1 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | – | – | – | 1,6 ETP | – | – | – | – | – | – | 0,1 ETP | – | – | – | – | – | – | – | – | – | |||||||||||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 7 ended
Active mandates
Eugene Bogaerts
ActiveKarel Roelands
ActiveKatleen Bogaerts
ActiveEnded mandates
Karel Roelands
EndedKarel Roelands
EndedKatleen Bogaerts
EndedKatleen BOGAERTS
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
SCARABEE● Active | 0793.871.853 |
TUMI THERAPEUTICS● Active | 0795.423.556 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 18/07/2025 | 31/08/2024 | 02/08/2023 | 27/06/2022 | 29/06/2021 |
| General meeting | 28/06/2026 | 30/06/2025 | 28/06/2024 | 30/06/2023 | 20/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 28/06/2026 | 30/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 18/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/06/2024 | 31/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 02/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 20/06/2022 | 27/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/06/2021 | 29/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 29/05/2020 | 06/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 31/05/2019 | 19/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 25/05/2018 | 04/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 26/05/2017 | 07/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 08/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/05/2015 | 02/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/05/2014 | 11/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 21/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/05/2012 | 29/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 27/05/2011 | 29/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 28/05/2010 | 30/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 29/05/2009 | 29/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/05/2008 | 30/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 25/05/2007 | 04/06/2007 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 7 ended
Active mandates
Eugene Bogaerts
ActiveKarel Roelands
ActiveKatleen Bogaerts
ActiveEnded mandates
Karel Roelands
EndedKarel Roelands
EndedKatleen Bogaerts
EndedKatleen BOGAERTS
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates04/08/2026ONTSLAGEN - BENOEMINGEN
- Other07/10/2025DOEL
- Restructuring06/01/2023BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring24/11/2022RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates07/04/2021ONTSLAGEN - BENOEMINGEN
- Capital / shares29/03/2018KAPITAAL - AANDELEN
- Mandates26/03/2018ONTSLAGEN - BENOEMINGEN
- Mandates23/08/2017ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-9,6 k €↓
- 2024Annual accounts 202413,7 k €↑
- 2023Annual accounts 2023-45,7 €↓
- 2022Annual accounts 202253 k €↑
- 2022Name changeOstara
- 2021Annual accounts 202148,9 k €↑
- 2020Annual accounts 202015,7 k €↑
- 2019Annual accounts 2019-9 k €↓
- 2018Annual accounts 20181,1 k €↓
- 2017Annual accounts 20179,6 k €↑
- 2016Annual accounts 2016-3,8 k €↓
- 2015Annual accounts 201568 k €↓
- 2015Name changeTumi Therapeutics
- 2014Annual accounts 2014111,6 k €↑
- 2013Annual accounts 201377,4 k €↑
- 2012Annual accounts 201271,6 k €↑
- 2011Annual accounts 201156,1 k €↓
- 2010Annual accounts 201073,1 k €↓
- 2009Annual accounts 200976,6 k €↓
- 2008Annual accounts 200885,5 k €↑
- 2007Annual accounts 200758,7 k €↓
- 2006Annual accounts 200675,8 k €
- 2006Name changeEBAC
- 14/11/2000IncorporationPrivate limited company